대한약학회 추계총회 및 학술대회 (2013년) Enzalutamide, Cabazitaxel, and Abiraterone for Overall Survival of Patients with Prostate Cancer after Docetaxel Treatment: An Indirect Comparison Analysis

학술대회자료

Enzalutamide, Cabazitaxel, and Abiraterone for Overall Survival of Patients with Prostate Cancer after Docetaxel Treatment: An Indirect Comparison Analysis

대한약학회
추계총회 및 학술대회
(2013년)
2013.10

701 - 701 (1 pages)

원문보기

원문저장

Enzalutamide, Cabazitaxel, and Abiraterone for Overall Survival of Patients with Prostate Cancer after Docetaxel Treatment: An Indirect Comparison Analysis

(0)

(0)

(0)

(0)

Enzalutamide, Cabazitaxel, and Abiraterone for Overall Survival of Patients with Prostate Cancer after Docetaxel Treatment: An Indirect Comparison Analysis

(0)

(0) 팝업 열기 팝업 닫기

(0)

(0)

(0)